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OBJECTIVE: The aim of this study was to analyze the effect of high-energy extracorporeal shockwave therapy on
tendon angiogenesis in the patellar tendons of rabbits. We sought to investigate whether different voltage and
number pulses modify the angiogenesis pattern.
INTRODUCTION: High-energy extracorporeal shockwave therapy is an option in the treatment of orthopedic
diseases such as chronic tendonitis. Despite its potential clinical applicability, there have been few studies on this
technique that examine both its clinical effectiveness and its effect on angiogenesis.
METHODS: High-energy extracorporeal shockwave therapy was applied at the tibial insertion of the left patellar
ligament in 30 rabbits that were separated into six groups that differed in terms of the voltage and number of
pulses that were applied by high-energy extracorporeal shockwave therapy. The tibial insertion in the right legs of
the animals was used as the control. After six weeks, we performed histological analysis on the region and
quantified the number of blood vessels.
RESULTS: No significant differences in the number of blood vessels between the left and right patellar tendons were
found within groups. Additionally, no significant differences in the number of blood vessels in the left patellar
tendons were found between groups.
CONCLUSIONS: The application of high-energy extracorporeal shockwave therapy did not cause a change in
vascularization in the patellar tendon in rabbits.
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INTRODUCTION
Treatment with high-energy extracorporeal shockwave
therapy (HEST) is currently used for the treatment
of musculoskeletal diseases.1-5 Among its main indica-
tions are the treatment of nonunion, chronic insertional
enthesopathies such as plantar fasciitis, lateral and
medial epicondylitis, calcaneal tendon tendinitis, and cal-
careal tendinitis of the shoulder. It is a therapeutic option
for cases in which conservative treatment has failed and
surgery is potentially indicated.1,4-7 There are some
theoretical advantages of HEST in comparison to surgical
treatment. Namely, HEST is noninvasive and fast, and it
does not require hospitalization, has a low complication
rate and high success rate, and has a relatively low cost.6
The utilization of HEST for the treatment of musculoske-
letal diseases began in 1986 when the first studies were
performed regarding its effects on bone. Animal model
studies have shown that HEST does not cause harmful
changes to normal bone and increases the osteogenic
potential through the activation of osteoblasts.4
HEST generates shockwaves that are transmitted through
different tissues, and the processes by which this occurs are
known.21 Most experimental work has aimed to analyze the
effect of HEST on bone.8-10 In contrast, few studies have
focused on the effects of HEST on soft tissue.11,12 Thus, little
is known about this subject.
To better understand HEST as a modality for the
treatment of soft-tissue musculoskeletal disorders, basic
science research should focus on local changes induced by
HEST and seek to determine which are responsible for the
improvements demonstrated in clinical studies.13-16 One
possibility for such an HEST-induced change is that HEST
could stimulate the formation of new blood vessels in the
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tendon and that it is this increased vascularization that leads
to clinical improvement.6,15,16
There are few experimental studies showing changes in
tendon vascularity after the application of extracorporeal
shockwaves (ESW),17,18 but there is evidence that HEST-
induced tissue changes are dose dependent.19 To find better
evidence of HEST-induced angiogenesis in soft tissues, we
designed this study to quantify the effects of HEST on
tendons. The aims of this study were to examine the effect of
HEST on the vascularity of the patellar tendon at its
insertion at the anterior tibial tuberosity and to determine
how varying the voltage and number of pulses applied
changed this effect.
MATERIALS AND METHODS
A total of 30 six-week-old New Zealand white female
rabbits were divided randomly into six groups of five
animals. The groups received HEST that differed by voltage
and the number of pulses (Table 1). The apparatus used for
the study was the OssaTronH (Barueri, SP, Brazil), which
was developed specifically for the treatment of musculos-
keletal disorders. This apparatus uses electrohydraulic
principles to generate shockwaves.
For the application of HEST, animals were anesthetized
by intramuscular injection of 50 mg/kg ketamine hydro-
chloride and 5 mg/kg diazepam. After the animals had
been anesthetized, the left knees were shaved. The applica-
tion site, the anterior tibial tuberosity, was located with the
aid of fluoroscopy and marked with a surgical marker pen.
The animals were placed on a table in the supine position,
and the device was positioned to direct the center of focus
precisely to the marked site. Shockwaves were applied to
the animal’s left knee. After the procedure, intramuscular
analgesics were provided to alleviate pain. The animals
were sacrificed by carbon dioxide inhalation six weeks after
HEST treatment, and the left and right patellar ligaments
were harvested. The right patellar ligament was used as a
control. The patellar ligaments were separated, fixed in 10%
formalin, dehydrated in increasing alcohol concentrations,
cleared in xylene, and embedded in paraffin in a manner
that allowed the resulting blocks to provide an assessment
of the entire ligament in the frontal plane. The paraffin
blocks were cut into 5 mm sections that were stained with
hematoxylin-eosin.
With the aid of a digital system (Image Tool 3.0;
Department of Dental Diagnostic Science at The University of
Texas Health Science Center, San Antonio, Texas), we analyzed
the entire length of the ligament insertion at the margin
(Figure 1). To cover the entire length of the insertional
ligament margin, sections were divided into fields (6–10
fields per section) and amplified 200 times. On the scanned
images, all obvious vascular structures were marked, i.e.,
those with patent lumens, those lined by endothelium, or
those containing red blood cells in the lumen. All of these
structures were counted, and the end result was expressed
in absolute numbers (Figure 2). Two independent obser-
vers, blinded to the distribution of the groups, examined
the images.
Statistical Analysis
The data were analyzed first to evaluate the distribution.
The Shapiro-Wilk test showed the data to be normally
distributed (p = 0.407). However, due to the small nature of
the groups sampled, we chose to perform nonparametric
testing. We calculated the mean number of vessels per slide,
and this value was used to represent each subject. We
determined the ratio between the total number of vessels and
the total number of fields for each sample. This ratio (vessels
per field) was used for statistical analysis. To standardize the
groups, we calculated the difference in the number of vessels
between the right and left patellar tendons of each animal.
These differences were used to compare the groups. The
nonparametric Wilcoxon test was used to compare themeans
of the number of vessels per field on the left and right legs
within each group. The Kruskall-Wallis test was performed
to compare groups when comparisons were made for more
than two groups. In all statistical tests, an a of 5% (p,0.05)
was considered significant.
The University’s ethics research committee approved this
study, which was conducted at the Department of Surgery of
the Hand and Upper Limb, Department of Orthopedics and
Traumatology, Escola Paulista de Medicina, Universidade
Federal de Sa˜o Paulo.
Table 2 - Blood vessels per field from HEST-treated (left)
and untreated (right) patellar tendons, indicating the
differences between them.
Groups N Vessels/Field R Vessels/Field L R-L difference p-value
1 4.00 3.92 0.08
2 4.28 3.14 1.14
1 3 7.19 8.81 -1.62
4 3.71 5.64 -1.93
5 - 7.57 * - 0.465 (1)
6 6.93 6.71 0.22
7 5.87 9.50 -3.63
2 8 5.00 6.00 -1.00
9 7.43 7.14 0.29
10 4.56 9.50 -4.94 0.225 (1)
11 - 3.50 * -
12 8.22 6.37 1.85
3 13 7.33 5.30 2.03
14 7.92 5.67 2.25
15 5.43 7.30 -1.87 0.273 (1)
16 7.62 3.71 3.91
17 5.62 10.08 -4.46
4 18 5.86 4.43 1.43
19 - 5.00 * -
20 10.00 8.00 2.00 0.751 (1)
21 7.28 7.17 0.11
22 - 5.37 * -
23 7.21 10.57 -3.36
5 24 9.00 * - -
25 10.86 11.00 0.14 0.285 (1)
26 4.29 4.94 -0.65
27 4.10 6.44 -2.34
6 28 2.62 4.50 -1.88
29 7.79 5.37 2.42 0.500 (1)
30 4.57 5.00 -0.43
0.438 (2)
(*) Excluded from the statistical analysis because of the lack of a matching
sample on the other side.
(1) Wilcoxon tests; (2) Kruskall-Wallis test.
Table 1 - Distribution of groups in terms of energy level in
kilovolts (kV) and the number of pulses applied.
Energy Pulses 14 kV 21 kV 28 kV
1000 Group 1 Group 2 Group 3
4000 Group 4 Group 5 Group 6
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RESULTS
Twenty-five animals were included in the study’s final
analysis. Five animals were excluded because of problems
related to histological analysis. Intergroup analyses indi-
cated that there was some difference within the control
groups (Kruskall-Wallis, X2 = 13.52; p= 0.031). This result
led us to perform comparisons of the mean difference
between the left and right patellar tendons of each animal
(R-L difference). There were no statistically significant
differences among groups in terms of the R-L difference
(Table 2, Kruskal-Wallis; X2 = 4.71; p= 0.438).
DISCUSSION
It is known that the etiology of insertional enthesopathies
is likely multifactorial, but the exact causes remain
unknown.5,8,19 It is thought that a degenerative process that
is accompanied by inflammation is important in pathogen-
esis.20 Authors have stated that the vascular changes and
hyaline degeneration observed in surgical biopsies from
insertional enthesopathy patients suggest that degeneration
has a greater role than inflammation in disease pathogenesis
and is the main etiological factor.20,21 However, there is
insufficient evidence to determine the best method for
treatment of the disease. As such, there are a considerable
number of options for treatment, including nonsteroidal
anti-inflammatory and hormonal therapy, detention, infil-
tration, acupuncture, and surgery.5,21
Currently, we use ESW therapy as an alternative treat-
ment for insertional enthesopathies and have achieved good
results with this approach.3,5,22-30 However, the mode of
action behind this treatment is still unknown. It has been
suggested that the pain in enthesopathies is the result
of reduced vascularization in degenerative tendon tissue
and that extracorporeal shockwave therapy could increase
neovascularization and promote tissue regeneration.21
There is little in the literature regarding experimental
research that is focused on understanding the effects of ESW
on tendons. One author concluded that the effects of ESW
are dependent on the amount of energy applied,5,19 while
others have observed an increased vascularization of treated
tendons after ESW therapy.1,31 Our work was designed to
verify whether ESW causes changes in tendon vasculariza-
tion, and if so, whether these changes would be dose-
dependent.
The International Society for Musculoskeletal Shockwave
Therapy advocates a normalization of the amount of energy to
be applied in each case, based on the disease in question and
the location of the ailment. Under these standards, the amount
of energy to be applied for the treatment of most entheso-
pathies is 1000 pulses of 16 kV.6 One experimental study
cautioned about the harmful effects of using greater than 1000
pulses of 21 kV because there was evidence that such a dose
could result in tendon tissue damage.5 In our study, we used a
broad spectrum of pulse-voltage combinations, with values
both within the recommended range and above, to test the
effects that HEST would have at different doses.
The tibial insertion of the patellar ligament was chosen as
the application site for HEST because it is a structure that is
easy to find and is relatively broad. These characteristics
allowed for proper positioning of the device, which allowed
us to focus the application of HEST correctly. In addition,
because this ligament has a large insertion area and is well
defined at one side, the demarcation of its margins was
straightforward.
While it is not confirmed that the improvement of pain
after ESW treatment of chronic enthesopathies is because of
the induction of angiogenesis in the tendon, there are
several reports that support this idea.17,18 A histochemical
study indicated that ESW appeared to induce the early
release of vascular growth factors from the tendon. These
growth factors induced angiogenesis, which led to increased
blood supply to the tendon, which in turn supported tissue
regeneration.18 Hsu et al. studied the effects of ESW in a
rabbit model of patellar tendinitis induced by the injection
of collagenase and found an increase in vascularization at 16
weeks.31 It is noteworthy that while all three of these studies
showed an increase in tendon vascularization after ESW
treatment, our results did not demonstrate such an increase.
It should also be noted that only one of these three studies is
comparable to our study in terms of the methodology used.
Each type of tissue has a particular impedance value. The
impedance of bone is much greater than that of water, and
therefore, bone absorbs large amounts of energy from
shockwaves. However, the impedance of a healthy tendon
is very similar to that of water, and thus, a tendon absorbs
less energy than bone. However, a calcified tendon has a
higher level of impedance because of the presence of
calcium crystals. This could explain why HEST is more
effective in cases of chronic enthesopathies because the
tendons in these cases tend to be tougher and more calcified
than in acute enthesopathies.6
We believe that more reliable results could be obtained if
we use an experimental model of induced calcification in
the tendon that simulates cases of chronic, calcified
enthesopathies. There is definitely a need for more research
on this topic.
Figure - 1A (left): Histological section of a patellar tendon stained with hematoxylin-eosin (2006). Checkpoint arrows represent
identified blood vessels. Figure - 1B (right): Patellar tendon section stained with hematoxylin-eosin (106).
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CONCLUSION
Within the energy range tested, high-energy shockwave
therapy did not cause significant changes in the vascularity
of insertional patellar tendons in a rabbit model.
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